Cargando…
Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies
BACKGROUND: Exploratory research showed that female oncologists are frequently under-represented in leadership roles. European Society for Medical Oncology (ESMO) Women for Oncology (W4O) therefore implemented gender equality programs in career development and established international studies on fe...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710465/ https://www.ncbi.nlm.nih.gov/pubmed/34924143 http://dx.doi.org/10.1016/j.esmoop.2021.100281 |
_version_ | 1784623159569285120 |
---|---|
author | Berghoff, A.S. Sessa, C. Yang, J.C.-H. Tsourti, Z. Tsang, J. Tabernero, J. Peters, S. Linardou, H. Letsch, A. Haanen, J. Garralda, E. Garassino, M.C. Furness, A.J.S. Felip, E. Dimopoulou, G. Dafni, U. Choo, S.P. Banerjee, S. Bajpai, J. Adjei, A.A. Garrido, P. |
author_facet | Berghoff, A.S. Sessa, C. Yang, J.C.-H. Tsourti, Z. Tsang, J. Tabernero, J. Peters, S. Linardou, H. Letsch, A. Haanen, J. Garralda, E. Garassino, M.C. Furness, A.J.S. Felip, E. Dimopoulou, G. Dafni, U. Choo, S.P. Banerjee, S. Bajpai, J. Adjei, A.A. Garrido, P. |
author_sort | Berghoff, A.S. |
collection | PubMed |
description | BACKGROUND: Exploratory research showed that female oncologists are frequently under-represented in leadership roles. European Society for Medical Oncology (ESMO) Women for Oncology (W4O) therefore implemented gender equality programs in career development and established international studies on female representation at all stages of the oncology career pathway. METHODS: For 2017-2019, data were collected on (i) first and last authorship of publications in five major oncology journals and (ii) representation of women in leadership positions in oncology—as invited speakers at National/International congresses, board members or presidents of National/International societies and ESMO members. The 2015/2016 data from the first published W4O Study were incorporated for comparisons. RESULTS: Across 2017-2019, female oncologists were significantly more likely to be first than last authors (P < 0.001). The proportion of female first authors was similar across years: 38.0% in 2017, 37.1% in 2018, 41.0% in 2019 (P = 0.063). The proportion of female last authors decreased from 30.4% in 2017 to 24.2% in 2018 (P = 0.0018) and increased to 28.5% in 2019 (P = 0.018). Across 2015-2019, invited speakers at International/National oncology congresses were significantly less likely to be female than male (P < 0.001; 29.7% in 2015 to 36.8% in 2019). Across 2016-2019, board members of International/National oncology societies were significantly less likely to be female than male (P < 0.001; 26.8% in 2016 to 35.8% in 2019). There were statistically significant increasing trends in female speakers and board members across the study periods (P < 0.001 for both). Societies with a female president had a higher proportion of female board members across these periods (P = 0.026). CONCLUSIONS: Reported progress towards gender equality in career development in oncology is real but slow. Women in leadership positions are essential for encouraging young women to aspire to and work towards similar or greater success. Therefore, continued monitoring is needed to inform ESMO W4O initiatives to promote gender balance at all stages of the career pathway. |
format | Online Article Text |
id | pubmed-8710465 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-87104652022-01-04 Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies Berghoff, A.S. Sessa, C. Yang, J.C.-H. Tsourti, Z. Tsang, J. Tabernero, J. Peters, S. Linardou, H. Letsch, A. Haanen, J. Garralda, E. Garassino, M.C. Furness, A.J.S. Felip, E. Dimopoulou, G. Dafni, U. Choo, S.P. Banerjee, S. Bajpai, J. Adjei, A.A. Garrido, P. ESMO Open Original Research BACKGROUND: Exploratory research showed that female oncologists are frequently under-represented in leadership roles. European Society for Medical Oncology (ESMO) Women for Oncology (W4O) therefore implemented gender equality programs in career development and established international studies on female representation at all stages of the oncology career pathway. METHODS: For 2017-2019, data were collected on (i) first and last authorship of publications in five major oncology journals and (ii) representation of women in leadership positions in oncology—as invited speakers at National/International congresses, board members or presidents of National/International societies and ESMO members. The 2015/2016 data from the first published W4O Study were incorporated for comparisons. RESULTS: Across 2017-2019, female oncologists were significantly more likely to be first than last authors (P < 0.001). The proportion of female first authors was similar across years: 38.0% in 2017, 37.1% in 2018, 41.0% in 2019 (P = 0.063). The proportion of female last authors decreased from 30.4% in 2017 to 24.2% in 2018 (P = 0.0018) and increased to 28.5% in 2019 (P = 0.018). Across 2015-2019, invited speakers at International/National oncology congresses were significantly less likely to be female than male (P < 0.001; 29.7% in 2015 to 36.8% in 2019). Across 2016-2019, board members of International/National oncology societies were significantly less likely to be female than male (P < 0.001; 26.8% in 2016 to 35.8% in 2019). There were statistically significant increasing trends in female speakers and board members across the study periods (P < 0.001 for both). Societies with a female president had a higher proportion of female board members across these periods (P = 0.026). CONCLUSIONS: Reported progress towards gender equality in career development in oncology is real but slow. Women in leadership positions are essential for encouraging young women to aspire to and work towards similar or greater success. Therefore, continued monitoring is needed to inform ESMO W4O initiatives to promote gender balance at all stages of the career pathway. Elsevier 2021-10-19 /pmc/articles/PMC8710465/ /pubmed/34924143 http://dx.doi.org/10.1016/j.esmoop.2021.100281 Text en © 2021 Published by Elsevier Ltd on behalf of European Society for Medical Oncology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research Berghoff, A.S. Sessa, C. Yang, J.C.-H. Tsourti, Z. Tsang, J. Tabernero, J. Peters, S. Linardou, H. Letsch, A. Haanen, J. Garralda, E. Garassino, M.C. Furness, A.J.S. Felip, E. Dimopoulou, G. Dafni, U. Choo, S.P. Banerjee, S. Bajpai, J. Adjei, A.A. Garrido, P. Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies |
title | Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies |
title_full | Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies |
title_fullStr | Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies |
title_full_unstemmed | Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies |
title_short | Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies |
title_sort | female leadership in oncology—has progress stalled? data from the esmo w4o authorship and monitoring studies |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710465/ https://www.ncbi.nlm.nih.gov/pubmed/34924143 http://dx.doi.org/10.1016/j.esmoop.2021.100281 |
work_keys_str_mv | AT berghoffas femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies AT sessac femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies AT yangjch femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies AT tsourtiz femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies AT tsangj femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies AT taberneroj femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies AT peterss femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies AT linardouh femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies AT letscha femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies AT haanenj femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies AT garraldae femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies AT garassinomc femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies AT furnessajs femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies AT felipe femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies AT dimopouloug femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies AT dafniu femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies AT choosp femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies AT banerjees femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies AT bajpaij femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies AT adjeiaa femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies AT garridop femaleleadershipinoncologyhasprogressstalleddatafromtheesmow4oauthorshipandmonitoringstudies |